DABRA Case Reports

DABRA technology has been utilized in the treatment of more than 10,000 patients in the United States and Europe and has been supported by extensive physician experience in complex peripheral interventions.

The platform is supported by FDA 510(k) clearances, clinical data, manufacturing documentation, and intellectual property acquired by IEVC in 2026 from Catheter Precision, successor company to Ra Medical Systems.